California gene therapy firm plans 200-job, $80M operation in Durham

Project Mercury, identified Thursday as a subsidiary of California-based Adverum Biotechnologies (NASDAQ: ADVM), is investing $80 million into a new facility in Durham — a 200-job commitment. Adverum picked Durham over competing sites in both California and Massachusetts, according to the North Carolina Department of Commerce, whose Economic Investments Committee approved the project for $3.3 million in incentives Thursday morning. Adverum, according to what th e company told N.C. Commerce, is…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news